Evidence map›Paper›PMID 27977707›Full record

Trial reportPloS one2016

Effect of Influenza Vaccination of Children on Infection Rate in Hutterite Communities: Follow-Up Study of a Randomized Trial.

Biao Wang, Margaret L Russell, Lorraine Moss, Kevin Fonseca, David J D Earn, Fred Aoki, Gregory Horsman, Paul Van Caeseele, Khami Chokani, Mark Vooght and 4 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00877396 (Does Vaccinating Health Hutterite Children Against Influenza Prevent Influenza in Other Hutterite Colony Members), which is not on this map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00877396 phase4completednot on this map

Does Vaccinating Health Hutterite Children Against Influenza Prevent Influenza in Other Hutterite Colony Members: A Randomized Cluster Trial

TypeinterventionalSponsorMcMaster UniversityRan2008 to 2011Enrolled4,771ConditionsInfluenzaArmsInfluenza vaccination, Hepatitis A Vaccine
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Effectiveness of Influenza Vaccines in the HIVE Household Cohort Over 8 Years: Is There Evidence of Indirect Protection?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  10. Article
  11. Influenza in Children.Cold Spring Harbor perspectives in medicine · 2021
    Review
  12. Article
  13. Low percentages of measles vaccination coverage with two doses of vaccine and low herd immunity levels explain measles incidence and persistence of measles in the European Union in 2017-2018.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Biao WangDepartment of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
Margaret L RussellDepartment of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Lorraine MossDepartment of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
Kevin FonsecaDepartment of Microbiology and Infectious Diseases and Provincial Laboratory for Public Health, University of Calgary, Calgary, Alberta, Canada.
David J D EarnDepartment of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
Fred AokiDepartments of Medicine, Medical Microbiology and Pharmacology, and Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada.
Gregory HorsmanSaskatchewan Disease Control Laboratory, Regina, Saskatchewan, Canada.
Paul Van CaeseeleCadham Provincial Laboratory, Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
Khami ChokaniSaskatchewan Health, Prince Albert Parkland Health Region, Prince Albert, Saskatchewan, Canada.
Mark VooghtSaskatchewan Health, Five Hills Health Region, Moose Jaw, Saskatchewan, Canada.
Lorne BabiukDepartment of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Canada.
Richard WebbySt Jude Children's Research Hospital and WHO Collaborating Center, Memphis, Tennessee, United States of America.
Stephen D WalterDepartment of Microbiology and Infectious Diseases and Provincial Laboratory for Public Health, University of Calgary, Calgary, Alberta, Canada.
Mark LoebDepartment of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
McMaster University · CAUniversity of Calgary · CASaskatchewan Health · CAUniversity of Manitoba · CASaskatchewan Disease Control Laboratory · CASt. Jude Children's Research Hospital · USUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAn earlier cluster randomized controlled trial (RCT) of Hutterite colonies had shown that if more than 80% of children and adolescents were immunized with influenza vaccine there was a statistically significant reduction in laboratory-confirmed influenza among all unimmunized community members. We assessed the impact of this intervention for two additional influenza seasonal periods.

methodsFollow-up data for two influenza seasonal periods of a cluster randomized trial involving 1053 Canadian children and adolescents aged 36 months to 15 years in Season 2 and 1014 in Season 3 who received the study vaccine, and 2805 community members in Season 2 and 2840 in Season 3 who did not receive the study vaccine. Follow-up for Season 2 began November 18, 2009 and ended April 25, 2010 while Season 3 extended from December 6, 2010 and ended May 27, 2011. Children were randomly assigned in a blinded manner according to community membership to receive either inactivated trivalent influenza vaccine or hepatitis A. The primary outcome was confirmed influenza A and B infection using RT-PCR assay. Due to the outbreak of 2009 H1N1 pandemic, data in Season 2 were excluded for analysis.

resultsFor an analysis of the combined Season 1 and Season 3 data, among non-recipients (i.e., participants who did not receive study vaccines), 66 of the 2794 (2.4%) participants in the influenza vaccine colonies and 121 of the 2301 (5.3%) participants in the hepatitis A colonies had influenza confirmed by RT-PCR, for a protective effectiveness of 60% (95% CI, 6% to 83%; P = 0.04); among all study participants (i.e., including both those who received study vaccine and those who did not), 125 of the 3806 (3.3%) in the influenza vaccine colonies and 239 of the 3243 (7.4%) in the hepatitis A colonies had influenza confirmed by RT-PCR, for a protective effectiveness of 63% (95% CI, 5% to 85%; P = 0.04).

conclusionImmunizing children and adolescents with inactivated influenza vaccine can offer a protective effect among unimmunized community members for influenza A and B together when considered over multiple years of seasonal influenza.

trial registrationClinicaltrials.gov NCT00877396.

Indexed as

Influenza VaccinesAdolescentCanadaChildChild, PreschoolDisease OutbreaksFemaleFollow-Up StudiesHumansIncidenceInfluenza, HumanMaleTreatment OutcomeInfluenza Vaccines

Identifiers

PMID27977707
PMCPMC5157992
OpenAlexW2564903874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.